Intriguingly, in contrast to our findings on RAD51B, others showed that hyperexpression of RAD51B in a subset of GC (Gastric Cancer) was significantly associated with poor prognosis and resistance to chemotherapy [29]. The gene discussed is RAD51B; the disease is gastric cancer.